Also listed on Bayer Schering Pharma AG, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 4, 2026 · High confidence
20-year base term ended Apr 25, 2023
Held by Adverio Pharma GmbH
Filed Jul 15, 2005 as application 10/513,869 · Granted Feb 6, 2007
Base term, 20 years from filing
Today
2003
2026
Clock starts
Apr 25, 2003
Apr 25, 2003
Term ends
Dec 4, 2026
Dec 4, 2026
Granted
Feb 6, 2007
Feb 6, 2007
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 25, 2003, when application PCT/EP2003/004304, the earliest non-provisional in its chain, was filed (this one was filed Jul 15, 2005) | Apr 25, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +1319 days, USPTO 35 U.S.C. 156 certificate | added to Apr 25, 2023: Dec 4, 2026 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 4, 2026 | High confidence |
This family
| US 7,173,037 | this patent Dec 2026 | Dec 2026 |
1 of 2 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 12, 2005 Reel 16249, frame 322 | Alonso-alija, Cristina; Bischoff, Erwin; Münter, Klaus; Stasch, Johannes-peter; Stahl, Elke; Weigand, Stefan; Feurer, Achim | Bayer Healthcare AG | Assignment of Assignor's Interest |
| Jan 12, 2010 Reel 23769, frame 122 | Bayer Healthcare AG | Bayer Schering Pharma Aktiengesellschaft | Merger |
| Feb 8, 2013 Reel 29780, frame 632 | Bayer Schering Pharma Aktiengesellschaft | Bayer Pharma Aktiengesellschaft | Change of Name |
| Feb 8, 2013 Reel 29780, frame 432 | Bayer Pharma Aktiengesellschaft | Bayer Intellectual Property GmbH | Assignment of Assignor's Interest |
| Mar 1, 2013 Reel 29908, frame 217 | Bayer Pharma Aktiengesellschaft | Bayer Intellectual Property GmbH | Assignment of Assignor's Interest |
| Apr 12, 2013 Reel 30202, frame 1 | Bayer Schering Pharma AG | Bayer Pharma Aktiengesellschaft | Change of Name |
| Dec 4, 2013 Reel 31716, frame 374 | Bayer Aktiengesellschaft | Bayer Intellectual Property GmbH | Assignment of Assignor's Interest |
| Dec 23, 2014 Reel 34577, frame 443 | Bayer Intellectual Property GmbH | Adverio Pharma GmbH | Assignment of Assignor's Interest |
| Jan 21, 2015 Reel 34839, frame 604 | Bayer Intellectual Property GmbH | Adverio Pharma GmbH | Corrective Assignment to Correct the Application Number 14217644 Previously Recorded at Reel: 034577 Frame: 0443. Assignor(S) Hereby Confirms the Assignment. |
| Feb 8, 2021 Reel 56907, frame 570 | Adverio Pharma GmbH | Adverio Pharma GmbH | Change of Patentee Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2026
Term ends Dec 4, 2026. No further fees fall due before then
Citations
123
later US patents cite this one
That is top 10% of utility patents granted in 2007 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.